Drosten M, Frilling A, Stiewe T, Pützer BM.
Inhibition of oncogenic RET signaling by Ad vector-mediated expression of a dominant-negative RET-mutant: implications for medullary thyroid cancer treatment.
Eur J Cancer 2002 ; 38:490 Suppl 7 Nov.
Previous Post
Implications of N-terminal truncated p73 for cancer.
Next Post
Inhibition of RET autophosphorylation by adenoviral expressed RET-delta TK: Implications for medullary thyroid carcinoma therapy.